Understanding Thyroid Autoimmunity: A Comprehensive Overview
Dr. Sofie Desforges-Bell, ND
C’est La Vie Wellness, Oakville + Mitchell
A Calm Retreat, Sebringville
Understanding Thyroid Autoimmunity: A Comprehensive Overview
What Is Thyroid Autoimmunity?
Thyroid autoimmunity, most commonly represented by Hashimoto’s Thyroiditis (HT), is the leading cause of primary hypothyroidism in iodine-sufficient countries like the United States and Canada. It is particularly prevalent in females. Globally, environmental iodine deficiency remains the most common cause of thyroid disorders, but where iodine is adequate, autoimmune thyroiditis takes the lead.
Hypothyroidism affects up to 5–10% of the population, with an estimated 5% having undiagnosed thyroid failure. Notably, approximately 33% of identified patients are not receiving adequate treatment, highlighting a significant gap in care.
How Is Hashimoto’s Diagnosed?
Hashimoto’s Thyroiditis is diagnosed through:
Positive thyroid antibodies: the two primary antibodies being Thyroid Peroxidase Antibodies (TPOAb) and Thyroglobulin Antibodies (TgAb)
Ultrasound imaging: which can reveal structural changes in the thyroid gland
Lymphocytic infiltration: considered the hallmark finding of Hashimoto’s, visible on both imaging and biopsy
It’s important to note that TSH levels can fluctuate widely, sometimes even within a 2–3 hour window, and should be interpreted as a trend rather than an absolute number.
The Disease Mechanism: What’s Actually Happening?
A common misconception is that thyroid antibodies are the primary cause of thyroid tissue destruction. In reality, antibodies are the end result of thyroid tissue damage, not the primary driver.
TPO antibodies may play a minor role in further destroying thyroid tissue cells, while Thyroglobulin antibodies are even less likely to have a direct causative role. The primary damage is driven by lymphocytic infiltration and pro-inflammatory signaling.
The Role of Antibody Levels
While antibody levels can provide some objective data for both clinicians and patients regarding risk, the clinical correlation between antibody levels and actual disease presentation is not fully understood. Current lab reporting in some regions (such as Canada) has limitations. For example, results may only differentiate up to a certain threshold, making it difficult to stratify risk based on very high antibody levels. This remains an area where more refined research is needed.
It is also worth noting that patients with Hashimoto’s disease may continue to experience persistent symptoms even when thyroid hormone levels appear normal, suggesting that thyroid autoimmunity itself, beyond just hormone levels, may play a role in how patients feel.
Gaps in Current Thyroid Care
Despite growing awareness, there remain significant gaps in both conventional and complementary/naturopathic approaches to thyroid care. Key areas of focus for improving patient outcomes include:
Pharmaceutical treatments tailored to the autoimmune component
Research-based therapeutics, including targeted supplements and nutrients
Special populations, such as individuals dealing with infertility, pregnancy, and postpartum thyroid issues, areas that require particular attention given the hormonal and immune shifts during these life stages
Key Takeaway
Thyroid autoimmunity is a complex, immune-mediated condition that goes far beyond simple hormone imbalance. A thorough understanding of its disease process, proper diagnostic workup, and individualized treatment strategies, including addressing the immune dysfunction at its root, are essential for optimal patient care.
Dr. Sofie Desforges-Bell, ND
C’est La Vie Wellness | Oakville & Mitchell